Figure 2.
Proportion of apoptotic intraepithelial lymphocytes (IELs). The result is representative of those obtained with 3 cynomolguses per group. The proportion of apoptotic IELs after alemtuzumab treatment for 9 days was significantly higher than the control group. *P < 0.05 compared with control group; †P > 0.05 compared with control group.